Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 7/20 | 0.68 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.68 |
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
| ▸ | FABP3 | P05413 | 2/20 | 0.48 |
| ▸ | FABP4 | P15090 | 2/20 | 0.48 |
| ▸ | GABRB1 | P18505 | 6/20 | 0.48 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.47 |
| ▸ | RXRA | P19793 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.41 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.41 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.41 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.41 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.41 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.41 |
| ▸ | FAAH | O00519 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL94533 | 0.87 | GABRA1 (0.77) | GABRA1GABRB2CA1CA2FABP3 | |
| Ammonia Solution, Strong SCHEMBL28098766 | 0.85 | GABRA1 (0.74) | GABRA1GABRB2CA1CA2FABP3 | |
| SCHEMBL1617739 | 0.81 | GABRA1 (1.00) | GABRA1GABRB2CA1CA2FABP3 | |
| SCHEMBL8780176 | 0.80 | GABRA1 (0.50) | GABRA1GABRB2CA1CA2FABP3 | |
| SCHEMBL6943696 | 0.79 | GABRA1 (0.65) | GABRA1GABRB2CA1CA2FABP3 | |
| SCHEMBL30467045 | 0.79 | GABRA1 (0.65) | GABRA1GABRB2CA1CA2FABP3 | |
| SCHEMBL26521897 | 0.77 | GABRA1 (0.63) | GABRA1GABRB2CA1CA2FABP3 | |
| SCHEMBL4862739 | 0.77 | GABRA1 (0.63) | GABRA1GABRB2CA1CA2FABP3 | |
| SCHEMBL6682827 | 0.77 | GABRA1 (0.63) | GABRA1GABRB2CA1CA2FABP3 | |
| SCHEMBL28111886 | 0.77 | CA1 (0.53) | GABRA1GABRB2CA1CA2FABP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2797938-B1 | METHOD FOR PRODUCING 6-CHLORODIBENZO [D,F][1,3,2]DIOXAPHOSPHEPIN | BASF SE (DE) | 2016-06-01 | — | — | EP | disclosed |
| EP-2797938-A1 | METHOD FOR PRODUCING 6-CHLORODIBENZO [D,F][1,3,2]DIOXAPHOSPHEPIN | BASF SE (DE) | 2014-11-05 | — | — | EP | disclosed |
| US-8841474-B2 | Process for preparing 6-chlorodibenzo[D,F][1,3,2]dioxaphosphepin | BASF SE (DE) | 2014-09-23 | — | — | US | disclosed |
| US-20130172596-A1 | PROCESS FOR PREPARING 6-CHLORODIBENZO[D,F][1,3,2]DIOXAPHOSPHEPIN | BASF SE (DE) | 2013-07-04 | — | — | US | disclosed |
| WO-2013098371-A1 | METHOD FOR PRODUCING 6-CHLORODIBENZO [D,F][1,3,2]DIOXAPHOSPHEPIN | BASF SE (DE) | 2013-07-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130172596-A1 | PROCESS FOR PREPARING 6-CHLORODIBENZO[D,F][1,3,2]DIOXAPHOSPHEPIN | DCPS, PLCB3, DDT | GABRA1 3715/4885GABRB2 3803/4885CA1 535/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.